HC Wainwright & Co. Reiterates Buy on Legend Biotech, Maintains $50 Price Target
Legend Biotech Corp LEGN
$28.12
▲ +4.38%
(+$1.18)
Open
$27.04
Prev Close
$26.94
Day Range
$26.72 – $28.27
52W Range
$16.24 – $45.30
Market Cap
$5.00B
Beta
0.33
EPS (TTM)
$-0.81
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-06-04 |
| Shares Out. | 371,480,000 |
| Website | investors.legendbiotech.com/ ↗ |
| Phone | 17328505598 |
Legend Biotech Corp is a publicly traded company under the ticker symbol LEGN on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
24 analysts (2026-05-01)
📰 Latest News for LEGN
Legend Biotech Corporation 2026 Q1 - Results - Earnings Call Presentation
These Analysts Revise Their Forecasts On Legend Biotech After Q1 Results
TD Cowen Maintains Hold on Legend Biotech, Raises Price Target to $29
Morgan Stanley Maintains Overweight on Legend Biotech, Lowers Price Target to $48
RBC Capital Maintains Outperform on Legend Biotech, Raises Price Target to $64
Legend Biotech Corporation (LEGN) Q1 2026 Earnings Call Transcript
Transcript : Legend Biotech Corporation, Q1 2026 Earnings Call, May 12, 2026